Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

2.2K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
2.2K
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

16.5K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
16.5K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
1.5K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

17.9K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
17.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reduced-Dose Post-Transplant Cyclophosphamide as Graft-Versus-Host Disease Prophylaxis in Matched Donor Allogeneic Stem Cell Transplantation: A Systematic Review of Efficacy and Toxicity.

Transplantation and cellular therapy·2026
Same author

Patient-physician familiarity is just as important for virtual outpatient encounters as for in-person encounters: a retrospective cohort study.

Scientific reports·2026
Same author

Anorectal Tuberculosis Presenting With Multiple Abscesses and Fistulas in a Young Adult Male Patient With Alcohol Use Disorder: A Case Report.

Cureus·2026
Same author

Investigating Associations Between Psychological Distress and Changes in Peripheral Blood Monocytes in Patients With CLL/SLL Managed With Active Surveillance.

Cancer medicine·2026
Same author

Futuristic global cell and gene therapy regulations based on a review of today's leading frameworks.

Cytotherapy·2026
Same author

Cerebrovascular Reactivity Assessment with Breath-Hold Functional MRI in Patients with Moyamoya Angiopathy: Which Time Period to Analyze?

Diagnostics (Basel, Switzerland)·2026

Related Experiment Video

Updated: Mar 22, 2026

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

12.7K

Central nervous system prophylaxis in diffuse large B-cell lymphoma.

Mohammad Faizan Zahid1, Nadia Khan2, Shahrukh K Hashmi3

  • 1Medical Graduate, Aga Khan University, Karachi, Pakistan.

European Journal of Haematology
|April 21, 2016
PubMed
Summary

Central nervous system (CNS) involvement in diffuse large B-cell lymphoma (DLBCL) often occurs during relapse. While CNS prophylaxis strategies exist, universal application is not yet justified due to varying efficacy and toxicity.

Keywords:
central nervous systemcentral nervous system involvementcentral nervous system relapsediffuse large B-cell lymphomaprophylaxis

More Related Videos

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

8.5K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

13.0K

Related Experiment Videos

Last Updated: Mar 22, 2026

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

12.7K
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

8.5K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

13.0K

Area of Science:

  • Hematology
  • Oncology
  • Neurology

Background:

  • Central nervous system (CNS) involvement is an uncommon but serious complication of diffuse large B-cell lymphoma (DLBCL).
  • CNS dissemination often occurs subclinically early in the disease course and is associated with poor patient outcomes upon relapse.
  • The incidence of CNS relapse has been impacted by the introduction of rituximab in DLBCL treatment regimens.

Purpose of the Study:

  • To review and compare various CNS prophylaxis strategies for DLBCL patients.
  • To discuss the advantages and disadvantages of different CNS prophylactic agents and administration methods.

Main Methods:

  • Literature review of studies reporting CNS prophylaxis in DLBCL.
  • Analysis of different chemotherapeutic agents and administration routes (intrathecal, high-dose systemic).

Main Results:

  • CNS relapse rates in DLBCL are approximately 5%, and universal prophylaxis is not universally recommended.
  • Rituximab has shown a significant reduction in CNS relapse incidence.
  • Various agents like intrathecal chemotherapy and high-dose systemic agents have been explored for CNS prophylaxis.

Conclusions:

  • No single CNS prophylaxis approach is definitively superior for DLBCL patients.
  • Prophylaxis, if administered, is preferably given during primary chemotherapy.
  • Further evidence is needed to establish optimal CNS prophylaxis strategies in DLBCL.